Benefits of CGM

How CGM Works

Continuous glucose monitoring (CGM) systems provide a glucose reading every five minutes, 288 times per day, giving you insights that routine fingersticks cannot match.

Small Sensor

A discreet sensor located just underneath your skin measures glucose levels.

Transmitter

Glucose data is sent wirelessly to an insulin pump* and compatible smart device via Bluetooth technology.

Insulin Pump Integration

The t:slim X2 insulin pump displays the current glucose reading from the CGM system plus a trend arrow and trend line. This makes it easy to see where you are now, spot trends, and catch high and low glucose events before they happen. When combined with current insulin on board, it helps you make informed treatment decisions.

Test Yourself

Even if you test your blood sugar as often as recommended, there’s a big part of the picture you’re not seeing with fingersticks alone.

What would you do at 5.7?

If your glucose continues to fall at the current rate, you could be below 3.3 mmol/L in the next 15 minutes.

Your glucose could move up or down by 0.8 mmol/L over the next 15 minutes, but you are holding steady.

If your glucose continues to rise at the current rate, you could be close to 8.3 mmol/L in the next 15 minutes.

Answer

When paired with Dexcom G6 CGM, the t:slim X2 insulin pump can help you visualize CGM trends so you can make real-time decisions based on real-time data. Plus, the t:slim X2 pump with Control-IQ technology has been shown to help simplify diabetes management by helping to prevent highs and lows while increasing time in range.

No Routine Fingersticks

Known for its exceptional accuracy and performance, Dexcom G6 CGM lets you make treatment decisions without pricking your finger for calibration or mealtime dosing. The t:slim X2 insulin pump is the only available pump that integrates with Dexcom CGM.^†

What’s next?

Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.

Get Started

Responsible Use of Control‑IQ Technology

Even with advanced systems such as Control-IQ technology, users are still responsible for actively managing their diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires that users accurately input information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless all system components, including CGM, infusion sets and pump cartridges, are used as instructed. Importantly, the system cannot adjust insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, users should always pay attention to their symptoms and treat accordingly.

* Dexcom CGM sold separately.

† No routine fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

This product may not be right for you. Always read and follow the label.

Important Safety Information

The t:slim X2 insulin pump with Control-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When used with a compatible CGM, the System can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The System can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The pump and the System are indicated for use in individuals 6 years of age and greater. The pump and the System are intended for single user use. The pump and the System are indicated for use with NovoRapid, Admelog, Trurapi, or Humalog U-100 insulin. The System is intended for the management of Type 1 diabetes.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

The System is not indicated for use in pregnant women, people on dialysis, or critically ill users. Do not use the System if using hydroxyurea.

Users of the pump and the System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

Benefits of CGM

How CGM Works

Insulin Pump Integration

Test Yourself

Answer

No Routine Fingersticks

Download Today

What’s next?

Responsible Use of Control‑IQ Technology

Resources & Support

Connected Care

Disclosures